These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

841 related items for PubMed ID: 18485394

  • 1. Can early single dose instillation of epirubicin improve bacillus Calmette-Guerin efficacy in patients with nonmuscle invasive high risk bladder cancer? Results from a prospective, randomized, double-blind controlled study.
    Cai T, Nesi G, Tinacci G, Zini E, Mondaini N, Boddi V, Mazzoli S, Bartoletti R.
    J Urol; 2008 Jul; 180(1):110-5. PubMed ID: 18485394
    [Abstract] [Full Text] [Related]

  • 2. Re: Can early single dose instillation of epirubicin improve bacillus calmette-guerin efficacy in patients with nonmuscle invasive high risk bladder cancer? Results from a prospective, randomized, double-blind controlled study: T. Cai, G. Nesi, G. Tinacci, E. Zini, N. Mondaini, v. Boddi, s. Mazzoli and R. Bartoletti J Urol 2008; 180: 110-115.
    Sylvester RJ, Oosterlinck W, O'Donnell M.
    J Urol; 2009 Jan; 181(1):410. PubMed ID: 19010500
    [No Abstract] [Full Text] [Related]

  • 3. The effect of intravesical instillation of antifibrinolytic agents on bacillus Calmette-Guerin treatment of superficial bladder cancer: a pilot study.
    Pan CW, Shen ZJ, Ding GQ.
    J Urol; 2008 Apr; 179(4):1307-11; discussion 1311-2. PubMed ID: 18289576
    [Abstract] [Full Text] [Related]

  • 4. Patterns of recurrence and outcomes following induction bacillus Calmette-Guerin for high risk Ta, T1 bladder cancer.
    Lerner SP, Tangen CM, Sucharew H, Wood D, Crawford ED.
    J Urol; 2007 May; 177(5):1727-31. PubMed ID: 17437798
    [Abstract] [Full Text] [Related]

  • 5. Loss of heterozygosis on IFN-alpha locus is a prognostic indicator of bacillus Calmette-Guerin response for nonmuscle invasive bladder cancer.
    Cai T, Nesi G, Dal Canto M, Tinacci G, Mondaini N, Piazzini M, Geppetti P, Bartoletti R.
    J Urol; 2010 May; 183(5):1738-43. PubMed ID: 20299058
    [Abstract] [Full Text] [Related]

  • 6. Sequential bacillus Calmette-Guerin and epirubicin versus bacillus Calmette-Guerin alone for superficial bladder tumors: a randomized prospective study.
    Ali-El-Dein B, Nabeeh A, Ismail EH, Ghoneim MA.
    J Urol; 1999 Aug; 162(2):339-42. PubMed ID: 10411034
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The effect of ofloxacin on bacillus calmette-guerin induced toxicity in patients with superficial bladder cancer: results of a randomized, prospective, double-blind, placebo controlled, multicenter study.
    Colombel M, Saint F, Chopin D, Malavaud B, Nicolas L, Rischmann P.
    J Urol; 2006 Sep; 176(3):935-9. PubMed ID: 16890660
    [Abstract] [Full Text] [Related]

  • 11. The role of tumor-free status in repeat resection before intravesical bacillus Calmette-Guerin for high grade Ta, T1 and CIS bladder cancer.
    Guevara A, Salomon L, Allory Y, Ploussard G, de la Taille A, Paul A, Yiou R, Hoznek A, Dahan M, Abbou CC, Vordos D.
    J Urol; 2010 Jun; 183(6):2161-4. PubMed ID: 20399454
    [Abstract] [Full Text] [Related]

  • 12. Nonprimary pT1 nonmuscle invasive bladder cancer treated with bacillus Calmette-Guerin is associated with higher risk of progression compared to primary T1 tumors.
    Alkhateeb SS, Van Rhijn BW, Finelli A, van der Kwast T, Evans A, Hanna S, Vajpeyi R, Fleshner NE, Jewett MA, Zlotta AR.
    J Urol; 2010 Jul; 184(1):81-6. PubMed ID: 20478593
    [Abstract] [Full Text] [Related]

  • 13. Predicting nonmuscle invasive bladder cancer recurrence and progression in patients treated with bacillus Calmette-Guerin: the CUETO scoring model.
    Fernandez-Gomez J, Madero R, Solsona E, Unda M, Martinez-Piñeiro L, Gonzalez M, Portillo J, Ojea A, Pertusa C, Rodriguez-Molina J, Camacho JE, Rabadan M, Astobieta A, Montesinos M, Isorna S, Muntañola P, Gimeno A, Blas M, Martinez-Piñeiro JA.
    J Urol; 2009 Nov; 182(5):2195-203. PubMed ID: 19758621
    [Abstract] [Full Text] [Related]

  • 14. Combined thermo-chemotherapy for recurrent bladder cancer after bacillus Calmette-Guerin.
    Nativ O, Witjes JA, Hendricksen K, Cohen M, Kedar D, Sidi A, Colombo R, Leibovitch I.
    J Urol; 2009 Oct; 182(4):1313-7. PubMed ID: 19683278
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Short-term administration of prulifloxacin in patients with nonmuscle-invasive bladder cancer: an effective option for the prevention of bacillus Calmette-Guérin-induced toxicity?
    Damiano R, De Sio M, Quarto G, Di Lorenzo G, Perdonà S, Palumbo IM, Azzarito G, Giugliano F, Autorino R.
    BJU Int; 2009 Sep; 104(5):633-9. PubMed ID: 19298412
    [Abstract] [Full Text] [Related]

  • 17. An analysis of the effect of statin use on the efficacy of bacillus calmette-guerin treatment for transitional cell carcinoma of the bladder.
    Berglund RK, Savage CJ, Vora KC, Kurta JM, Cronin AM.
    J Urol; 2008 Oct; 180(4):1297-300; discussion 1300. PubMed ID: 18707737
    [Abstract] [Full Text] [Related]

  • 18. Randomized study of single instillation of epirubicin for superficial bladder carcinoma: long-term clinical outcomes.
    Liu B, Wang Z, Chen B, Yu J, Zhang P, Ding Q, Zhang Y.
    Cancer Invest; 2006 Mar; 24(2):160-3. PubMed ID: 16537185
    [Abstract] [Full Text] [Related]

  • 19. Intravesical Bacillus Calmette-Guérin Versus Combination of Epirubicin and Interferon-α2a in Reducing Recurrence of Non-Muscle-invasive Bladder Carcinoma: FinnBladder-6 Study.
    Marttila T, Järvinen R, Liukkonen T, Rintala E, Boström P, Seppänen M, Tammela T, Hellström P, Aaltomaa S, Leskinen M, Raitanen M, Kaasinen E, FinnBladder Group.
    Eur Urol; 2016 Aug; 70(2):341-7. PubMed ID: 27085624
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 43.